View in EDS HTML Full Text PDF Full Text

Safety and Antiviral Activity of EGFR Inhibition by Erlotinib in Chronic Hepatitis C Patients: A Phase Ib Randomized Controlled Trial.

Saved in:
Bibliographic Details
Title: Safety and Antiviral Activity of EGFR Inhibition by Erlotinib in Chronic Hepatitis C Patients: A Phase Ib Randomized Controlled Trial.
Authors: Saviano A; Inserm, U1110, Strasbourg, France.; Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg, Strasbourg, France.; Institut Hospitalo-Universitaire, Service d'hépato-gastroentérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Centre d'Investigation Clinique, Inserm 1434, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Institut Universitaire de France (IUF), Paris, France., Habersetzer F; Inserm, U1110, Strasbourg, France.; Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg, Strasbourg, France.; Institut Hospitalo-Universitaire, Service d'hépato-gastroentérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Centre d'Investigation Clinique, Inserm 1434, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Institut Universitaire de France (IUF), Paris, France., Lupberger J; Inserm, U1110, Strasbourg, France.; Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg, Strasbourg, France., Simo-Noumbissie P; Institut Hospitalo-Universitaire, Service d'hépato-gastroentérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Schuster C; Inserm, U1110, Strasbourg, France.; Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg, Strasbourg, France., Doffoël M; Institut Hospitalo-Universitaire, Service d'hépato-gastroentérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Schmidt-Mutter C; Centre d'Investigation Clinique, Inserm 1434, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Baumert TF; Institut Universitaire de France (IUF), Paris, France.
Source: Clinical and translational gastroenterology [Clin Transl Gastroenterol] 2022 Jun 01; Vol. 13 (6), pp. e00492. Date of Electronic Publication: 2022 Jun 01.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101532142 Publication Model: Electronic Cited Medium: Internet ISSN: 2155-384X (Electronic) Linking ISSN: 2155384X NLM ISO Abbreviation: Clin Transl Gastroenterol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35363627
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and Antiviral Activity of EGFR Inhibition by Erlotinib in Chronic Hepatitis C Patients: A Phase Ib Randomized Controlled Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Saviano+A%22">Saviano A</searchLink>; Inserm, U1110, Strasbourg, France.; Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg, Strasbourg, France.; Institut Hospitalo-Universitaire, Service d'hépato-gastroentérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Centre d'Investigation Clinique, Inserm 1434, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Institut Universitaire de France (IUF), Paris, France.<br /><searchLink fieldCode="AU" term="%22Habersetzer+F%22">Habersetzer F</searchLink>; Inserm, U1110, Strasbourg, France.; Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg, Strasbourg, France.; Institut Hospitalo-Universitaire, Service d'hépato-gastroentérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Centre d'Investigation Clinique, Inserm 1434, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Institut Universitaire de France (IUF), Paris, France.<br /><searchLink fieldCode="AU" term="%22Lupberger+J%22">Lupberger J</searchLink>; Inserm, U1110, Strasbourg, France.; Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Simo-Noumbissie+P%22">Simo-Noumbissie P</searchLink>; Institut Hospitalo-Universitaire, Service d'hépato-gastroentérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Schuster+C%22">Schuster C</searchLink>; Inserm, U1110, Strasbourg, France.; Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Doffoël+M%22">Doffoël M</searchLink>; Institut Hospitalo-Universitaire, Service d'hépato-gastroentérologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Schmidt-Mutter+C%22">Schmidt-Mutter C</searchLink>; Centre d'Investigation Clinique, Inserm 1434, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Baumert+TF%22">Baumert TF</searchLink>; Institut Universitaire de France (IUF), Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101532142%22">Clinical and translational gastroenterology</searchLink> [Clin Transl Gastroenterol] 2022 Jun 01; Vol. 13 (6), pp. e00492. <i>Date of Electronic Publication: </i>2022 Jun 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%22">Wolters Kluwer Health </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532142 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2155-384X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222155384X%22">2155384X </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Gastroenterol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35363627
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.14309/ctg.0000000000000492
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e00492
    Titles:
      – TitleFull: Safety and Antiviral Activity of EGFR Inhibition by Erlotinib in Chronic Hepatitis C Patients: A Phase Ib Randomized Controlled Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Saviano A
      – PersonEntity:
          Name:
            NameFull: Habersetzer F
      – PersonEntity:
          Name:
            NameFull: Lupberger J
      – PersonEntity:
          Name:
            NameFull: Simo-Noumbissie P
      – PersonEntity:
          Name:
            NameFull: Schuster C
      – PersonEntity:
          Name:
            NameFull: Doffoël M
      – PersonEntity:
          Name:
            NameFull: Schmidt-Mutter C
      – PersonEntity:
          Name:
            NameFull: Baumert TF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2022 Jun 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2155-384X
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical and translational gastroenterology
              Type: main
ResultId 1